Carlsbad, CA, United States of America

Mason Yamashita

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ionis Pharmaceuticals, Inc.. Active years: 2017-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mason Yamashita. Retrieved from https://idiyas.com/inventor/mason-yamashita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7


 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mason Yamashita: Innovator in Cancer Treatment

Introduction

Mason Yamashita is a prominent inventor based in Carlsbad, CA (US). He has made significant contributions to the field of cancer treatment, holding a total of 3 patents. His work focuses on innovative methods and compounds aimed at combating serious forms of cancer.

Latest Patents

Yamashita's latest patents include groundbreaking methods for treating B-cell lymphoma and hepatocellular carcinoma. These patents detail the use of compounds and compositions that inhibit the expression of STAT3 mRNA or protein in animals. Such advancements are crucial for developing effective treatments to prevent or ameliorate these types of cancer.

Career Highlights

Mason Yamashita is currently associated with Ionis Pharmaceuticals, Inc., where he continues to push the boundaries of cancer research. His dedication to innovation in medical treatments has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Yamashita collaborates with notable professionals in his field, including his coworker Stanley T. Crooke. These partnerships enhance the research and development of new therapeutic strategies.

Conclusion

Mason Yamashita's contributions to cancer treatment through his innovative patents and collaborations highlight his commitment to improving patient outcomes. His work continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…